Article thumbnail

Intestinal fermentation in patients with self-reported food hypersensitivity: painful, but protective?

By Jørgen Valeur, Mette Helvik Morken, Elisabeth Norin, Tore Midtvedt and Arnold Berstad
Topics: Original Research
Publisher: Dove Medical Press
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2002). A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics.
  2. (1993). Alpha glucosidase deficiencies as a possible cause of irritable bowel syndrome (IBS). Gastroenterology.
  3. Antibiotic or bacterial therapy in post-giardiasis irritable bowel syndrome.
  4. Carbohydrate intolerance in patients with self-reported food hypersensitivity: comparison of lactulose and glucose.
  5. (2002). Cellulolytic bacteria in human gut and irritable bowel syndrome. Acta Vet Brno.
  6. Colonic fermentation to short-chain fatty acids is decreased in antibiotic-associated diarrhea.
  7. (1994). Concentrations and correlations of faecal short-chain fatty acids and faecal water content in man. Microb Ecol Health Dis.
  8. (2005). Correlation between fecal iso-butyric and iso-valeric acids in different species. Microb Ecol Health Dis.
  9. De Vuyst L. Letter to the editor.
  10. Diet and the evolution of human amylase gene copy number variation.
  11. (2008). Effect of butyrogenic fibers in IBS patients.
  12. Fecal bacterial activity in symptomatic carbohydrate malabsorption: effect on the fecal short-chain fatty acid ratio.
  13. (1996). Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation.
  14. (1991). Food allergy – or enterometabolic disorder? Lancet.
  15. Food hypersensitivityimmunologic (peripheral) or cognitive (central) sensitization?
  16. (2010). Indications of `atopic bowel` in patients with self-reported food hypersensitivity. Aliment Pharmacol Ther.
  17. (2008). Lifestyle of patients with self-reported food hypersensitivity differ little from controls. Gastroenterol Nurs.
  18. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring).
  19. Plasma glucagonlike peptide 1 and peptide YY levels are not altered in symptomatic fructose-sorbitol malabsorption.
  20. Pretreatment methods prior to gaschromatographic analysis of volatile fatty acids from faecal samples.
  21. Probiotics in gnotobiotic mice: Short-chain fatty acids production in vitro and in vivo.
  22. Psychological stress and the passage of a standard meal through the stomach and small intestine in man.
  23. Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats.
  24. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrateproducing bacteria in feces.
  25. Relations between transit time, fermentation products, and hydrogen consuming flora in healthy humans.
  26. (2008). Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther.
  27. Self-reported diarrhea: what does it mean?
  28. Short chain fatty acid distributions of enema samples from a sigmoidoscopy population: an association of high acetate and low butyrate ratios with adenomatous polyps and colon cancer.
  29. Short-chain fatty acids and the irritable bowel syndrome: the effect of wheat bran.
  30. Short-chain fatty acids in the normal human feces.
  31. The effect of starch malabsorption on fecal short-chain fatty acid excretion in man.
  32. The effects of butyrate enemas on visceral perception in healthy volunteers.
  33. The fecal microbial population in the irritable bowel syndrome.
  34. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects.
  35. The influence of antibiotics upon microflora associated characteristics in man and animals.
  36. (1997). The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther.
  37. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease.
  38. (2010). The relationship between symptoms, body mass index, gastrointestinal transit, and stool frequency in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol.
  39. The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial.